This is the second webinar in the BioMedical SIG webinar series, “From Research to Development – Paths to Cross the Valley of Death in Life Sciences”, which showcases initiatives available to European KTOs to maturate technologies with potential in TRL and CRL, without the creation of a spin-off.
In this session, speakers Peter Nussbaumer and Gernot Faustmann will present the KHAN/w4i/LDC initiative. This collaborative drug discovery platform facilitates the translation of world-class science into innovative therapies for the benefit of patients. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. They focus on first-in-class therapies for attractive markets with a high unmet medical need.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
Excellent organisation, multifarious activities, great atmosphere… I can't say enough about how well it is tailored to the needs of technology transfer professions.
Tamara Čolić Milosavljević
Centre of Technology Transfer - University of Belgrade, Serbia
This was the right decision giving me the broadest overview, confidence, tools, network and support that is fundamental to feel right in my daily decision process and to keep on learning.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
The course Software Specific Challenges is a must for every TTO/KTO professional, especially for those working with Social Sciences and Humanities!
Brechtje Vreenegoor
Radboud University, Netherlands
The event had something to offer all members of the TT community from entry level to mid-career and beyond.
John Gleeson
University of Limerick, Ireland
It is always encouraging to see that other TTOs are encountering the same problems that we do!
Aurore De Boom
Université Libré de Bruxelle, Belgium
Join our newsletter and get the latest news